Kite and Refuge Biotechnologies Announce Exclusive License Agreement for Investigational Gene Expression Platform for Blood Cancers

Got To Article
Kite, a Gilead Company (Nasdaq: GILD) and Refuge Biotechnologies, Inc. ("Refuge"), today announced that Kite has entered into an exclusive, worldwide license agreement with Refuge, a synthetic biology company for cancer immunotherapy,
0 comments

In Partnership with Global Genes, Congenital Hyperinsulinism International Hosts Inaugural Family Meet-Up

Got To Article
Global Genes, a leading patient advocacy organization, and Congenital Hyperinsulinism International (CHI), a foremost nonprofit dedicated to improving the lives of children and adults living with congenital hyperinsulinism (HI),
0 comments

Cornerstone Launches Talent Experience Platform: New Blueprint for Workforce Transformation

Got To Article
Cornerstone OnDemand, Inc., a leader in talent experience solutions, today announced the release of its new Talent Experience Platform (TXP) designed to help talent leaders unlock the limitless potential of their workforce and streamline the way they do it.
0 comments

A CHRISTMAS CAROL to Return to A Noise Within This Holiday Season

Got To Article
Universally acclaimed for its innovative staging, whimsical costumes, original music and boundless good cheer, the delightfully festive, musically merry stage adaptation by Geoff Elliott of Charles Dickens’ A Christmas Carol returns to A Noise Within this holiday season from December 3 through December 23.
0 comments